Zacks Investment Research
19 May 2026, 14:55 UTC · 2d ago
Source · https://www.zacks.com/stock/news/2923367/wall-street-analysts-see-a-38-75-upside-in-anaptysbio-anab-can-the-stock-really-move-this-high?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2923367
Read source
Search tags
Story key points
3 claims · impact-rated
Analysts have collectively revised earnings estimates upward for AnaptysBio, Inc. (ANAB). — Positive earnings estimate revisions are a strong fundamental signal that typically precedes stock price appreciation.
+0.40The mean analyst price target for ANAB is $81.5, representing a potential 38.8% upside from its last close of $58.74. — While price targets provide a bullish benchmark, the text explicitly notes their potential for bias and unreliability.
+0.20ANAB shares have increased by 15.3% over the previous four weeks. — Recent price momentum indicates positive market sentiment but is a lagging indicator compared to earnings revisions.
+0.10Impact vectors
3 dimensions · 9 clusters
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Ticker attribution
Model heads
The stock has gained 15.3% recently and has a mean analyst price target suggesting significant further upside.
No ticker relationship head found.
